Contraception and reproductive planning during the COVID-19 pandemic

Expert Rev Clin Pharmacol. 2020 Jun;13(6):615-622. doi: 10.1080/17512433.2020.1782738. Epub 2020 Jun 22.


Introduction: The coronavirus disease (COVID-19) is a global health emergency. Major disruption to healthcare services during the current COVID-19 pandemic will last even after its peak. Sexual and reproductive health (SRH), specially contraception, needs to be understood as an essential service.

Areas covered: This paper is a narrative review. Data from PubMed/MEDLINE, Scopus, and websites of scientific societies were screened during the months of April and May 2020. It addresses the main aspects related to contraception during the COVID-19 pandemic, with special emphasis on family planning services, extended use of long-acting reversible contraceptive (LARC) methods, drug interactions, and thromboembolism risk. We also specified some issues focused on the Brazilian reality.

Expert opinion: Ensuring proper contraception use in the COVID-19 time is very important. We encourage women, healthcare providers, policymakers, and the society to consider SRH services as priority.

Keywords: COVID-19; Contraception; SARS-CoV-2; coronavirus; family planning; reproductive health.

Publication types

  • Review

MeSH terms

  • Adult
  • Betacoronavirus*
  • COVID-19
  • Contraception*
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / epidemiology*
  • Drug Interactions
  • Family Planning Services*
  • Female
  • Humans
  • Pandemics
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / epidemiology*
  • Reproductive Health
  • SARS-CoV-2
  • Sexual Health
  • Venous Thromboembolism / etiology